Related Experiment Video
Updated: Mar 6, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Impact of global work index on obesity paradox in heart failure with advanced left ventricle remodeling
Roubai Pan1, Xierenayi Tudi1, Weiwei Jiang1
1Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
In heart failure patients with advanced left ventricular remodeling, higher myocardial work (global work index) modifies the obesity paradox, suggesting obesity may be protective. This highlights the importance of considering myocardial function when assessing prognosis.
Area of Science:
- Cardiology
- Heart Failure Research
- Obesity Medicine
Background:
- The obesity paradox in heart failure suggests lower body mass index (BMI) is associated with worse outcomes.
- Advanced left ventricular remodeling is a key factor in heart failure prognosis.
- The role of myocardial work in this paradox remains unclear.
Purpose of the Study:
- To investigate the influence of myocardial work, specifically the global work index (GWI), on the obesity paradox in heart failure patients with advanced left ventricular remodeling.
- To assess the prognostic impact of obesity at different GWI levels in this patient population.
Main Methods:
- A post hoc analysis of 515 heart failure patients (LVEF ≤50%) hospitalized between May 2016 and December 2020.
- Advanced left ventricular remodeling defined by left ventricular mass index (LVMI).
- Primary endpoint: major adverse cardiovascular events (MACE). Prognostic impact of BMI and GWI assessed.
Main Results:
- Of 515 patients, 330 had advanced left ventricular remodeling (LVMI thresholds met).
- In this subgroup, BMI ≥28 kg/m² was linked to lower MACE risk.
- Higher GWI subgroup (n=139) showed reduced MACE with higher BMI; no association in lower GWI subgroup (n=191).
Conclusions:
- Myocardial work index significantly modifies the relationship between BMI and prognosis in heart failure.
- GWI is a crucial factor for evaluating the obesity paradox in patients with left ventricular systolic dysfunction and advanced remodeling.
Aims:
This study aimed to examine the role of myocardial work in the obesity paradox among heart patients with heart failure and advanced left ventricular remodeling.
Methods:
In this post hoc analysis, 515 consecutive patients with LVEF ≤ 50% who were hospitalized between May 2016 and December 2020 were included and followed for a median of 37.4 months. Left ventricular mass index (LVMI) was used to define advanced left ventricular remodeling. The primary endpoint was major adverse cardiovascular events (MACE). We assessed the prognostic impact of obesity at different levels of the global work index (GWI) in patients with advanced left ventricular remodeling.
Results:
Of the 515 patients, 330 were classified as having advanced left ventricular remodeling based on LVMI thresholds (men ≥110 g/m2, women ≥120 g/m2). In this subgroup, a BMI ≥ 28 kg/m2 was associated with a lower risk of MACE. These 330 patients were further stratified into higher GWI (n = 139) and lower GWI (n = 191) subgroups. In the higher GWI subgroup, both BMI ≥ 28 kg/m2 and continuous BMI values were associated with a reduced risk of MACE. No such association was observed in the lower GWI subgroup.
Conclusion:
Myocardial work index modifies the relationship between BMI and prognosis in heart failure. GWI should be considered when evaluating the obesity paradox in patients with left ventricular systolic dysfunction, particularly those with advanced left ventricular remodeling.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction